Dr. Clay Siegall: Innovator, Visionary, Philanthropist

There are many people in this world whom have done some amazing things to better man-kind. These people can be found on all continents and they also come from different colors, races, and creed. The sad thing about these extraordinary individuals is that they’re not well known unlike the celebrities and entertainers of today. In cancer research, there is one guy who has redefined and reshaped the landscape in the fight against cancer and this guy is known as Dr. Clay Siegall. This brilliant minded individual is well known and respected throughout this exclusive industry. His resume is remarkable as he’s won numerous industry related awards, raised over a billion dollars for cancer research, and he’s the current holder of 15 patents.

Dr. Siegall has a long list of satisfied patients thanks to his extensive knowledge in cancer research. He’s the President and CEO for one of the leading biotech centers in the world. Seattle Genetics is the name and cancer research is it’s game. This organization specializes in the development and commercialization of cancer breakthrough therapies and it’s flagship drug ADCETRIS is one of the most successful medications in history. This therapy is known as an antibody drug conjugate and it injects a killing blow straight into cancerous cells without harming any of the good cells within the body. Dr. Siegall has secured strategic licensing of ADCETRIS with some of the biggest names in the industry such as Pfizer, GlaxoSmithKline, and Genentech. With this licensing deal, ADCETRIS can now be used worldwide and it has been in well over 60 countries. Dr. Siegall’s business savvy approach has caused Seattle Genetics to rack up more than $350 Million to this very day.

You won’t find a more achieved leader than Dr. Siegall. He has laid the foundation of success through rigorous research, scientific innovation, and drug development.